118 related articles for article (PubMed ID: 11583782)
21. Salicylamide and salicylglycine oxidovanadium complexes with insulin-mimetic properties.
Nilsson J; Shteinman AA; Degerman E; Enyedy EA; Kiss T; Behrens U; Rehder D; Nordlander E
J Inorg Biochem; 2011 Dec; 105(12):1795-800. PubMed ID: 22056176
[TBL] [Abstract][Full Text] [Related]
22. Insulin-enhancing activity of a dinuclear vanadium complex: 5-chloro-salicylaldhyde ethylenediamine oxovanadium(V) and its permeability and cytotoxicity.
Xie MJ; Yang XD; Liu WP; Yan SP; Meng ZH
J Inorg Biochem; 2010 Aug; 104(8):851-7. PubMed ID: 20434776
[TBL] [Abstract][Full Text] [Related]
23. A new insulin-mimetic vanadyl complex, (N-pyridylmethylaspartate)oxovanadium(IV) with VO(N2O2) coordination mode, and evaluation of its effect on uptake of D-glucose by Ehrlich ascites tumour cells.
Tawa R; Uchida K; Taniyama J; Fujisawa Y; Fujimoto S; Nagaoka T; Kanamori K; Sakurai H
J Pharm Pharmacol; 1999 Feb; 51(2):119-24. PubMed ID: 10217308
[TBL] [Abstract][Full Text] [Related]
24. Molecular, supramolecular and solution structures of peroxovanadium complexes with ON and O3N donor set ligands: two new types of cationic-anionic peroxovanadium(V) peroxovanadates(V).
Mad'arová M; Sivák M; Kuchta L; Marek J; Benko J
Dalton Trans; 2004 Oct; (20):3313-20. PubMed ID: 15483716
[TBL] [Abstract][Full Text] [Related]
25. Chemistry and insulin-mimetic properties of bis(acetylacetonate)oxovanadium(IV) and derivatives.
Amin SS; Cryer K; Zhang B; Dutta SK; Eaton SS; Anderson OP; Miller SM; Reul BA; Brichard SM; Crans DC
Inorg Chem; 2000 Feb; 39(3):406-16. PubMed ID: 11229556
[TBL] [Abstract][Full Text] [Related]
26. Study of the antidiabetic capacity of the VO(dmpp)2 complex.
Passadouro M; Metelo AM; Melão AS; Pedro JR; Faneca H; Carvalho E; Castro MM
J Inorg Biochem; 2010 Sep; 104(9):987-92. PubMed ID: 20627316
[TBL] [Abstract][Full Text] [Related]
27. Bis(allixinato)oxovanadium(IV) complex is a potent antidiabetic agent: studies on structure-activity relationship for a series of hydroxypyrone-vanadium complexes.
Adachi Y; Yoshida J; Kodera Y; Katoh A; Takada J; Sakurai H
J Med Chem; 2006 Jun; 49(11):3251-6. PubMed ID: 16722643
[TBL] [Abstract][Full Text] [Related]
28. A new family of insulin-mimetic vanadium complexes derived from 5-carboalkoxypicolinates.
Gätjens J; Meier B; Kiss T; Nagy EM; Buglyó P; Sakurai H; Kawabe K; Rehder D
Chemistry; 2003 Oct; 9(20):4924-35. PubMed ID: 14562311
[TBL] [Abstract][Full Text] [Related]
29. Structural and redox requirements for the action of anti-diabetic vanadium compounds.
Yoshikawa Y; Sakurai H; Crans DC; Micera G; Garribba E
Dalton Trans; 2014 May; 43(19):6965-72. PubMed ID: 24668346
[TBL] [Abstract][Full Text] [Related]
30. Stepwise Cluster Assembly Using VO(2)(acac) as a Precursor: cis-[VO(OCH(CH(3))(2))(acac)(2)], [V(2)O(2)(&mgr;-OCH(3))(2)(acac)(2)(OCH(3))(2)], [V(3)O(3){&mgr;,&mgr;-(OCH(2))(3)CCH(3)}(2)(acac)(2)(OC(2)H(5))], and [V(4)O(4)(&mgr;-O)(2)(&mgr;-OCH(3))(2)(&mgr;(3)-OCH(3))(2)(acac)(2)(OCH(3))(2)].2CH(3)CN(1).
Jiang F; Anderson OP; Miller SM; Chen J; Mahroof-Tahir M; Crans DC
Inorg Chem; 1998 Oct; 37(21):5439-5451. PubMed ID: 11670686
[TBL] [Abstract][Full Text] [Related]
31. Complexes of hydroxy(thio)pyrone and hydroxy(thio)pyridinone with Zn(II) and Mo(VI). Thermodynamic stability and insulin-mimetic activity.
Chaves S; Jelic R; Mendonça C; Carrasco M; Yoshikawa Y; Sakurai H; Santos MA
Metallomics; 2010 Mar; 2(3):220-7. PubMed ID: 21069160
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, characterisation, reactivity and in vitro antiamoebic activity of hydrazone based oxovanadium(IV), oxovanadium(V) and mu-bis(oxo)bis{oxovanadium(V)} complexes.
Maurya MR; Agarwal S; Abid M; Azam A; Bader C; Ebel M; Rehder D
Dalton Trans; 2006 Feb; (7):937-47. PubMed ID: 16462954
[TBL] [Abstract][Full Text] [Related]
33. Bis- and tris(pyridyl)amine-oxidovanadium complexes: characteristics and insulin-mimetic potential.
Nilsson J; Degerman E; Haukka M; Lisensky GC; Garribba E; Yoshikawa Y; Sakurai H; Enyedy EA; Kiss T; Esbak H; Rehder D; Nordlander E
Dalton Trans; 2009 Oct; (38):7902-11. PubMed ID: 19771353
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of insulin signaling pathway in adipocytes by oxovanadium(IV) complexes.
Basuki W; Hiromura M; Adachi Y; Tayama K; Hattori M; Sakurai H
Biochem Biophys Res Commun; 2006 Oct; 349(3):1163-70. PubMed ID: 16970914
[TBL] [Abstract][Full Text] [Related]
35. Characterization of oxovanadium (IV) complexes of D-gluconic and D-saccharic acids and their bioactivity on osteoblast-like cells in culture.
Williams PA; Barrio DA; Etcheverry SB; Baran EJ
J Inorg Biochem; 2004 Feb; 98(2):333-42. PubMed ID: 14729313
[TBL] [Abstract][Full Text] [Related]
36. Aqueous V(V)-peroxo-amino acid chemistry. Synthesis, structural and spectroscopic characterization of unusual ternary dinuclear tetraperoxo vanadium(V)-glycine complexes.
Gabriel C; Kaliva M; Venetis J; Baran P; Rodriguez-Escudero I; Voyiatzis G; Zervou M; Salifoglou A
Inorg Chem; 2009 Jan; 48(2):476-87. PubMed ID: 19072216
[TBL] [Abstract][Full Text] [Related]
37. Effect of vanadium(IV) compounds in the treatment of diabetes: in vivo and in vitro studies with vanadyl sulfate and bis(maltolato)oxovandium(IV).
Willsky GR; Goldfine AB; Kostyniak PJ; McNeill JH; Yang LQ; Khan HR; Crans DC
J Inorg Biochem; 2001 May; 85(1):33-42. PubMed ID: 11377693
[TBL] [Abstract][Full Text] [Related]
38. Antitumor activity and toxicity of peroxo heteroligand vanadates(V) in relation to biochemistry of vanadium.
Djordjevic C; Wampler GL
J Inorg Biochem; 1985 Sep; 25(1):51-5. PubMed ID: 3850106
[TBL] [Abstract][Full Text] [Related]
39. Potential insulinominetic agents of zinc(II) complexes with picolinamide derivatives: preparations of complexes, in vitro and in vivo studies.
Ueda E; Yoshikawa Y; Ishino Y; Sakurai H; Kojima Y
Chem Pharm Bull (Tokyo); 2002 Mar; 50(3):337-40. PubMed ID: 11911195
[TBL] [Abstract][Full Text] [Related]
40. Vanadium-induced formation of thiadiazole and thiazoline compounds. Mononuclear and dinuclear oxovanadium(v) complexes with open-chain and cyclized thiosemicarbazone ligands.
Rubcić M; Milić D; Horvat G; Dilović I; Galić N; Tomisić V; Cindrić M
Dalton Trans; 2009 Nov; (44):9914-23. PubMed ID: 19885541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
